Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ELAN – Elanco Animal Health Incorporated

Float Short %

4.45

Margin Of Safety %

12

Put/Call OI Ratio

1.33

EPS Next Q Diff

0.16

EPS Last/This Y

0.26

EPS This/Next Y

0.11

Price

21.7

Target Price

25.23

Analyst Recom

1.56

Performance Q

16.48

Relative Volume

1.09

Beta

1.88

Ticker: ELAN




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17ELAN21.421.520.8151079
2025-11-18ELAN21.391.520.0151060
2025-11-19ELAN21.441.240.0255489
2025-11-20ELAN21.231.240.0055557
2025-11-21ELAN22.271.140.0457653
2025-11-24ELAN23.091.250.0044478
2025-11-25ELAN23.441.230.0344870
2025-11-26ELAN23.31.181.5046082
2025-12-01ELAN22.631.180.4946051
2025-12-02ELAN22.51.5021.0552803
2025-12-03ELAN22.181.320.2249348
2025-12-04ELAN21.991.310.5649552
2025-12-05ELAN21.91.311.1349797
2025-12-08ELAN21.671.310.0749976
2025-12-09ELAN20.431.240.3651977
2025-12-10ELAN21.31.140.2154332
2025-12-11ELAN21.31.361.2550423
2025-12-12ELAN21.281.330.6450594
2025-12-15ELAN21.681.330.0950654
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17ELAN21.42-22.7456.10.93
2025-11-18ELAN21.38-22.7448.00.93
2025-11-19ELAN21.46-22.7450.40.93
2025-11-20ELAN21.23-22.7443.90.93
2025-11-21ELAN22.27-21.0471.40.94
2025-11-24ELAN23.10-21.0466.80.94
2025-11-25ELAN23.43-21.0455.80.94
2025-11-26ELAN23.32-21.0446.50.94
2025-12-01ELAN22.62-21.0435.70.94
2025-12-02ELAN22.49-21.0446.20.94
2025-12-03ELAN22.18-21.0442.40.94
2025-12-04ELAN21.99-21.0444.80.94
2025-12-05ELAN21.90-21.0447.00.94
2025-12-08ELAN21.69-21.0- 0.94
2025-12-09ELAN20.43-21.1421.70.94
2025-12-10ELAN21.30-21.6468.40.94
2025-12-11ELAN21.30-21.6447.20.94
2025-12-12ELAN21.29-22.0449.30.94
2025-12-15ELAN21.70-22.0457.80.94
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17ELAN0.0017.694.48
2025-11-18ELAN0.0017.694.48
2025-11-19ELAN0.0017.694.48
2025-11-20ELAN0.0017.694.48
2025-11-21ELAN0.0017.694.48
2025-11-24ELAN0.007.244.48
2025-11-25ELAN0.007.244.48
2025-11-26ELAN0.007.244.56
2025-12-01ELAN0.007.284.56
2025-12-02ELAN0.007.284.56
2025-12-03ELAN0.007.284.56
2025-12-04ELAN0.007.284.56
2025-12-05ELAN0.007.284.56
2025-12-08ELAN0.007.324.56
2025-12-09ELAN0.007.324.56
2025-12-10ELAN0.007.324.45
2025-12-11ELAN0.007.324.45
2025-12-12ELAN0.007.324.45
2025-12-15ELAN0.747.324.45
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ELAN" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.19

Avg. EPS Est. Current Quarter

0.11

Avg. EPS Est. Next Quarter

0.35

Insider Transactions

0.74

Institutional Transactions

7.32

Beta

1.88

Average Sales Estimate Current Quarter

1093

Average Sales Estimate Next Quarter

1280

Fair Value

24.28

Quality Score

56

Growth Score

71

Sentiment Score

64

Actual DrawDown %

42.1

Max Drawdown 5-Year %

-78

Target Price

25.23

P/E

297.67

Forward P/E

20.96

PEG

2.5

P/S

2.35

P/B

1.6

P/Free Cash Flow

29.3

EPS

0.07

Average EPS Est. Cur. Y​

0.94

EPS Next Y. (Est.)

1.04

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.78

Relative Volume

1.09

Return on Equity vs Sector %

-26.5

Return on Equity vs Industry %

-6.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

457.8
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ELAN” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ELAN” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ELAN” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ELAN” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ELAN” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ELAN” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ELAN” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Elanco Animal Health Incorporat
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 9000
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
stock quote shares ELAN – Elanco Animal Health Incorporated Stock Price stock today
news today ELAN – Elanco Animal Health Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch ELAN – Elanco Animal Health Incorporated yahoo finance google finance
stock history ELAN – Elanco Animal Health Incorporated invest stock market
stock prices ELAN premarket after hours
ticker ELAN fair value insiders trading